This randomized controlled trial investigated whether pharmacogenetic clinical guideline interventions of either a dose adjustment or switching to a different SSRI in the intervention group resulted in improved depression

Nong and colleagues have published a systematic review and meta-analysis in the BMJ which compares benefits and adverse effects of drugs used in the management of obesity.

The American Academy of Neurology together with the American Headache Society recently published new practice guidelines for pharmacologic options for migraine prophylaxis.